These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21170084)

  • 21. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
    Sun H; Lin DC; Cao Q; Guo X; Marijon H; Zhao Z; Gery S; Xu L; Yang H; Pang B; Lee VK; Lim HJ; Doan N; Said JW; Chu P; Mayakonda A; Thomas T; Forscher C; Baloglu E; Shacham S; Rajalingam R; Koeffler HP
    Cancer Res; 2016 May; 76(9):2687-97. PubMed ID: 26956669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.
    Hoxha S; Shepard A; Troutman S; Diao H; Doherty JR; Janiszewska M; Witwicki RM; Pipkin ME; Ja WW; Kareta MS; Kissil JL
    Cancer Res; 2020 Jun; 80(12):2512-2522. PubMed ID: 32409309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP oncogene overexpression supercharges colon cancer proliferation.
    Avruch J; Zhou D; Bardeesy N
    Cell Cycle; 2012 Mar; 11(6):1090-6. PubMed ID: 22356765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
    Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
    Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
    Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
    Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c‑Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway.
    Luo G; Li B; Duan C; Cheng Y; Xiao B; Yao F; Wei M; Tao Q; Feng C; Xia X; Zhou H; Zhao X; Dai R
    Oncol Rep; 2017 Oct; 38(4):2498-2506. PubMed ID: 28849072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.
    Song LB; Li J; Liao WT; Feng Y; Yu CP; Hu LJ; Kong QL; Xu LH; Zhang X; Liu WL; Li MZ; Zhang L; Kang TB; Fu LW; Huang WL; Xia YF; Tsao SW; Li M; Band V; Band H; Shi QH; Zeng YX; Zeng MS
    J Clin Invest; 2009 Dec; 119(12):3626-36. PubMed ID: 19884659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.
    Abaan OD; Levenson A; Khan O; Furth PA; Uren A; Toretsky JA
    Oncogene; 2005 Apr; 24(16):2715-22. PubMed ID: 15782144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.
    Sugita S; Arai Y; Tonooka A; Hama N; Totoki Y; Fujii T; Aoyama T; Asanuma H; Tsukahara T; Kaya M; Shibata T; Hasegawa T
    Am J Surg Pathol; 2014 Nov; 38(11):1571-6. PubMed ID: 25007147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.
    Huang L; Nakai Y; Kuwahara I; Matsumoto K
    Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
    Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
    Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.
    Huertas-Martínez J; Court F; Rello-Varona S; Herrero-Martín D; Almacellas-Rabaiget O; Sáinz-Jaspeado M; Garcia-Monclús S; Lagares-Tena L; Buj R; Hontecillas-Prieto L; Sastre A; Azorin D; Sanjuan X; López-Alemany R; Moran S; Roma J; Gallego S; Mora J; García Del Muro X; Giangrande PH; Peinado MA; Alonso J; de Alava E; Monk D; Esteller M; Tirado OM
    Cancer Lett; 2017 Feb; 386():196-207. PubMed ID: 27894957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.
    Wiederschain D; Chen L; Johnson B; Bettano K; Jackson D; Taraszka J; Wang YK; Jones MD; Morrissey M; Deeds J; Mosher R; Fordjour P; Lengauer C; Benson JD
    Mol Cell Biol; 2007 Jul; 27(13):4968-79. PubMed ID: 17452456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways.
    Shi C; Cai Y; Li Y; Li Y; Hu N; Ma S; Hu S; Zhu P; Wang W; Zhou H
    Redox Biol; 2018 Apr; 14():59-71. PubMed ID: 28869833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.
    He S; Huang Q; Hu J; Li L; Xiao Y; Yu H; Han Z; Wang T; Zhou W; Wei H; Xiao J
    Br J Cancer; 2019 Nov; 121(11):922-933. PubMed ID: 31649319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.